Diagnostic Testing Systems—COVID-19, Cancer, Viruses, GI, Blood, and More
Minnesota Rubber & Plastics has partnered with numerous medical companies to design and manufacture a wide range of medical diagnostic testing systems.
These point-of-care diagnostic testing systems are critical to address immediate patient needs such as those impacted by COVID-19. Our quick and rapid response to partner with customers that have received EUA (Emergency Use Authorizations) for their devices is helping to bring accurate and reliable testing systems to the market in response to this global pandemic.
Additionally, we help develop and manufacture cancer diagnostic systems. These systems include tissue-based diagnostic solutions and personalized treatment options like immunotherapies, which encourage the body’s immune system to target and kill cancer cells.
Other diagnostics include tests for blood culture identification, gastrointestinal conditions, meningitis, encephalitis, pneumonia and other viruses.
Custom Materials and Components that Complement any Reagent
The biggest challenge to developing components for diagnostic testing is formulating materials that can sustain chemical reactions with our clients’ proprietary reagents.
Because reagents are considered industry secrets, our chemists and scientists work methodically, yet swiftly, to find a material that complements the company’s reagent, while maintaining component integrity.
How We Develop Custom Materials
To optimize how our custom materials complement proprietary reagents, we leverage our advanced materials lab. Materials experts adhere to the scientific method and use a broad range of analytical instruments to perfect ideal materials:
- Infrared Spectrometer (FTIR)
- Infrared Microscope
- Differential Scanning Calorimetry (DSC)
- Thermogravimetric Analysis (TGA)
- Rubber Process Analyzer (RPA)
- Moving Die Rheometer (MDR)
- UV-Vis Spectrophotometer